by Jordana Choucair | Nov 18, 2021 | Opioid/Substance Use Disorders
More than 3,300 lawsuits have been filed against drug manufacturers, distributors, and pharmacies for their role in exacerbating the country’s opioid epidemic. Recognizing that final verdicts in these legal proceedings could take years, Senior Director Tym Rourke...
by Jordana Choucair | Nov 18, 2021 | Opioid/Substance Use Disorders
Provisional data from the CDC shows that an estimated 100,306 people in the U.S. died from a drug overdose in a 12-month period ending April 2021. It’s the first time drug overdose fatalities reached six figures in a single year, and signals that the country is...
by Jordana Choucair | Nov 16, 2021 | Opioid/Substance Use Disorders
Washington Attorney General Bob Ferguson argued in court that three large drug distributors violated the state’s public nuisance and consumer protection laws because they didn’t have tracking systems in place to prevent illegitimate sales and distribution of...
by Jordana Choucair | Nov 12, 2021 | Opioid/Substance Use Disorders
Michael Bloomberg announced that Bloomberg Philanthropies is making a $120 million investment to help address the opioid epidemic. Five states – Kentucky, New Jersey, New Mexico, North Carolina, and Wisconsin – will each receive $10 million over the next five years....
by Jordana Choucair | Nov 10, 2021 | Opioid/Substance Use Disorders
The Oklahoma Supreme Court reversed a 2019 ruling that required Johnson & Johnson to pay the state $465 million for its role in the opioid epidemic. In a 5-1 vote, the court rejected the state’s argument that the company violated “public nuisance” laws by...
by Jordana Choucair | Nov 2, 2021 | Opioid/Substance Use Disorders
A superior court judge in California became the first judge to reject government claims that opioid makers should be held responsible for the addiction crisis. The judge ruled that a handful of opioid manufacturers, including Johnson & Johnson, Teva Pharmaceutical...
Recent Comments